NXGN — Nextgen Healthcare Income Statement

0.000.00%

Last trade - 00:00

TechnologyBalancedMid Cap

Annual income statement for Nextgen Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	529	540	557	596	653
Cost of Revenue
Gross Profit	282	273	281	301	311
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	498	535	544	590	657
Operating Profit	31.6	5.11	12.8	6.66	-3.87
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	29.3	4.26	9.28	5.2	4.3
Provision for Income Taxes
Net Income After Taxes	24.7	7.5	9.52	1.62	-2.65
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	24.5	7.5	9.52	1.62	-2.65
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	24.5	7.5	9.52	1.62	-2.65
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.391	0.264	0.221	0.066	0.256
Dividends per Share